AI and data science aim to predict IBD treatment shifts

NCT ID NCT05733702

Recruiting now Knowledge-focused Sponsor: Luxembourg Institute of Health Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study is collecting health data, voice recordings, and biological samples from 100 IBD patients in Luxembourg (part of a larger 800-person study across Europe). Researchers hope to find patterns that can predict when a patient's treatment needs to change. The goal is to use artificial intelligence and data science to improve personalized care for Crohn's disease and ulcerative colitis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors predict when IBD patients need a treatment change, leading to more personalized and timely care.
What could go wrong: This is an observational study, not testing a new treatment. It may not find clear markers, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATORY BOWEL DISEASES

Contacts and locations

Locations

Centre Hospitalier de Luxembourg (CHL)
RECRUITING

Luxembourg, L-1210, Luxembourg

More trials for these conditions

Other studies related to the condition(s) this trial covers.